These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22850496)

  • 1. Cost-effectiveness analysis of intrathecal baclofen therapy in Japan.
    Hattori N; Hirayama T; Katayama Y
    Neurol Med Chir (Tokyo); 2012; 52(7):482-7. PubMed ID: 22850496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of intrathecal baclofen therapy for the treatment of severe spasticity associated with cerebral palsy.
    de Lissovoy G; Matza LS; Green H; Werner M; Edgar T
    J Child Neurol; 2007 Jan; 22(1):49-59. PubMed ID: 17608306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical cost impact of intrathecal baclofen therapy for severe spasticity.
    Saulino M; Guillemette S; Leier J; Hinnenthal J
    Neuromodulation; 2015 Feb; 18(2):141-9; discussion 149. PubMed ID: 25145312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal Baclofen Therapy in Patients With Multiple Sclerosis: Improved Outcomes and Reduced Costs Through Identification of Catheter Malfunction.
    Nelson MES; McGuire JR
    Neuromodulation; 2019 Oct; 22(7):839-842. PubMed ID: 31157471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost analysis of the treatment of severe spinal spasticity with a continuous intrathecal baclofen infusion system.
    Postma TJ; Oenema D; Terpstra S; Bouma J; Kuipers-Upmeijer H; Staal MJ; Middel BJ
    Pharmacoeconomics; 1999 Apr; 15(4):395-404. PubMed ID: 10537958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of Intrathecal Baclofen Therapy in severe refractory non-focal disabling spasticity: a Spanish hospital perspective.
    Vidal J; Slof J; Serrano D; Marqués T; Kumru H; Benito-Penalva J
    Expert Rev Pharmacoecon Outcomes Res; 2017 Feb; 17(1):67-76. PubMed ID: 27142176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional benefits and cost/benefit analysis of continuous intrathecal baclofen infusion for the management of severe spasticity.
    Sampson FC; Hayward A; Evans G; Morton R; Collett B
    J Neurosurg; 2002 Jun; 96(6):1052-7. PubMed ID: 12066906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraventricular baclofen as an alternative to intrathecal baclofen for intractable spasticity or dystonia: outcomes and technical considerations.
    Turner M; Nguyen HS; Cohen-Gadol AA
    J Neurosurg Pediatr; 2012 Oct; 10(4):315-9. PubMed ID: 22861196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term intrathecal baclofen: outcomes after more than 10 years of treatment.
    Mathur SN; Chu SK; McCormick Z; Chang Chien GC; Marciniak CM
    PM R; 2014 Jun; 6(6):506-513.e1. PubMed ID: 24355547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quality of life in cerebral palsy children treated with intrathecal baclofen pump implantation in parents' opinion].
    Borowski A; Pruszczyński B; Miller F; Synder M
    Chir Narzadow Ruchu Ortop Pol; 2010; 75(5):318-22. PubMed ID: 21853903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The need for and provision of intrathecal baclofen therapy for the management of spasticity in England: an assessment of the Hospital Episode Statistics database.
    Narendran RC; Duarte RV; Valyi A; Eldabe S
    BMJ Open; 2015 Jun; 5(6):e007517. PubMed ID: 26129634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intrathecal baclofen therapy to spasticity].
    Mizusawa H
    Rinsho Shinkeigaku; 2007 Nov; 47(11):951-3. PubMed ID: 18210845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal Baclofen Therapy for the Treatment of Spasticity in Lithuania.
    Kvascevicius R; Lapteva O; Kesiene J; Vaitkus A; Mikulenaite L; Raugalas R; Sipylaite J; Rocka S; Juocevicius A
    J Neurol Surg A Cent Eur Neurosurg; 2017 May; 78(3):281-285. PubMed ID: 27903018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Intrathecal Baclofen on Pain and Quality of Life in Poststroke Spasticity.
    Creamer M; Cloud G; Kossmehl P; Yochelson M; Francisco GE; Ward AB; Wissel J; Zampolini M; Abouihia A; Calabrese A; Saltuari L
    Stroke; 2018 Sep; 49(9):2129-2137. PubMed ID: 30354975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The underutilization of intrathecal baclofen in poststroke spasticity.
    Dvorak EM; Ketchum NC; McGuire JR
    Top Stroke Rehabil; 2011; 18(3):195-202. PubMed ID: 21642057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness modeling of intrathecal baclofen therapy versus other interventions for disabling spasticity.
    Bensmail D; Ward AB; Wissel J; Motta F; Saltuari L; Lissens J; Cros S; Beresniak A
    Neurorehabil Neural Repair; 2009; 23(6):546-52. PubMed ID: 19228818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal baclofen in multiple sclerosis: too little, too late?
    Erwin A; Gudesblatt M; Bethoux F; Bennett SE; Koelbel S; Plunkett R; Sadiq S; Stevenson VL; Thomas AM; Tornatore C; Zaffaroni M; Hughes M
    Mult Scler; 2011 May; 17(5):623-9. PubMed ID: 21282321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of intrathecal baclofen therapy on spasticity in patients with brain injury].
    Dénes Z; Klauber A; Both B; Lóránd E
    Ideggyogy Sz; 2012 Jul; 65(7-8):243-8; discussion 248. PubMed ID: 23074844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuromodulation using intrathecal baclofen therapy for spasticity and dystonia.
    Uchiyama T; Nakanishi K; Fukawa N; Yoshioka H; Murakami S; Nakano N; Kato A
    Neurol Med Chir (Tokyo); 2012; 52(7):463-9. PubMed ID: 22850493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spasticity and intrathecal baclofen.
    Furr-Stimming E; Boyle AM; Schiess MC
    Semin Neurol; 2014 Nov; 34(5):591-6. PubMed ID: 25520030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.